Jeffrey MBA - IMAC Holdings Chairman CEO
| BACK Stock | USD 1.39 0.03 2.11% |
Insider
Jeffrey MBA is Chairman CEO of IMAC Holdings
| Age | 46 |
| Address | 1605 Westgate Circle, Brentwood, TN, United States, 37027 |
| Phone | 844 266 4622 |
| Web | https://www.imacholdings.com |
IMAC Holdings Management Efficiency
The company has return on total asset (ROA) of (0.3802) % which means that it has lost $0.3802 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.3219) %, meaning that it created substantial loss on money invested by shareholders. IMAC Holdings' management efficiency ratios could be used to measure how well IMAC Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, IMAC Holdings' Return On Capital Employed is quite stable compared to the past year. Return On Equity is expected to rise to 0.01 this year, although the value of Return On Tangible Assets will most likely fall to (0.01). Change To Liabilities is expected to rise to about 354.5 K this year, although the value of Total Current Liabilities will most likely fall to about 1.8 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael McAlevey | HCA Holdings | 60 | |
| Mat Varghese | agilon health | N/A | |
| Kevin Mullins | Lifestance Health Group | 39 | |
| Kassi APR | P3 Health Partners | N/A | |
| Brent Guerisoli | Pennant Group | 43 | |
| Ed Reisz | Aveanna Healthcare Holdings | 65 | |
| James II | P3 Health Partners | N/A | |
| FACEP FACP | P3 Health Partners | 62 | |
| Ravi Sachdev | agilon health | 44 | |
| Cheyenne Ross | P3 Health Partners | N/A | |
| David CFA | Acadia Healthcare | N/A | |
| James Zsebok | Novo Integrated Sciences | 58 | |
| J Morrow | HCA Holdings | 50 | |
| Richy MD | Oncology Institute | N/A | |
| Hugh Johnston | HCA Holdings | 59 | |
| David Bourdon | Lifestance Health Group | 54 | |
| MD MBA | Oncology Institute | 47 | |
| Michelle Gourdine | agilon health | 57 | |
| MD JD | Acadia Healthcare | N/A | |
| Philip Reger | Oncology Institute | N/A | |
| Tony Strange | Aveanna Healthcare Holdings | 61 | |
Management Performance
| Return On Equity | -3.32 | ||||
| Return On Asset | -0.38 |
IMAC Holdings Leadership Team
Elected by the shareholders, the IMAC Holdings' board of directors comprises two types of representatives: IMAC Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IMAC. The board's role is to monitor IMAC Holdings' management team and ensure that shareholders' interests are well served. IMAC Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IMAC Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, CFO Secretary | ||
| Norleidy Hernandez, Human Director | ||
| Sheri CPA, CFO Secretary | ||
| Frank III, Director Sales | ||
| Ben Lerner, Chief Officer | ||
| Sandy Miller, Chief Staff | ||
| Jeffrey MBA, Chairman CEO | ||
| Matthew Wallis, President Director | ||
| Faith Zaslavsky, Chief Officer |
IMAC Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IMAC Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.32 | ||||
| Return On Asset | -0.38 | ||||
| Current Valuation | 7.59 M | ||||
| Shares Outstanding | 1.72 M | ||||
| Shares Owned By Insiders | 8.79 % | ||||
| Shares Owned By Institutions | 4.30 % | ||||
| Number Of Shares Shorted | 16.46 K | ||||
| Price To Book | 0.54 X | ||||
| Price To Sales | 0.59 X | ||||
| Revenue | 5.2 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in IMAC Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy IMAC Stock please use our How to buy in IMAC Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IMAC Holdings. If investors know IMAC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IMAC Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.03) | Revenue Per Share 7.719 | Quarterly Revenue Growth (0.59) | Return On Assets (0.38) | Return On Equity (3.32) |
The market value of IMAC Holdings is measured differently than its book value, which is the value of IMAC that is recorded on the company's balance sheet. Investors also form their own opinion of IMAC Holdings' value that differs from its market value or its book value, called intrinsic value, which is IMAC Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IMAC Holdings' market value can be influenced by many factors that don't directly affect IMAC Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IMAC Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if IMAC Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IMAC Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.